Global Non-steroidal Anti-inflammatory Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration, By Distribution Channel, By Route of Disease Indication, By Regional Outlook and Forecast, 2022

List of Tables

The Global Non-Steroidal Anti-inflammatory Drugs Market size is expected to reach $25.5 billion by 2028, rising at a market growth of 5.7% CAGR during the forecast period.

Non-steroidal anti-inflammatory medications (NSAIDs) are used to alleviate pain, lower fevers, and improve blood circulation. Furthermore, the inflammation is decreased when high dosages of non-steroidal anti-inflammatory medicines (NSAIDs) are given. Non-steroidal medications have sedative and anti-inflammatory effects. Inflammation is caused by the COX-1 and COX-2 enzymes that are inhibited by non-steroidal anti-inflammatory medications (NSAIDs). Aspirin, naproxen, ibuprofen, and paracetamol are examples of typical non-steroidal anti-inflammatory medications.

The market for non-steroidal anti-inflammatory medications (NSAIDs) is expanding as a result of a number of causes, including the growing incidence of chronic pain worldwide and an ageing population. The expanding use of NSAIDs for headache, toothache, migraine, and menstrual pain, as well as growing preference for OTC NSAIDs, are also anticipated to contribute to the growth over the forecast period. Additionally, the accessibility of a wide range of NSAID products as well as an increase in product approvals and launches are projected to fuel growth over the forecast period.

During the projected period, the prevalence of chronic pain is anticipated to increase, driving NSAID market growth. For instance, the CDC estimates that in the United States, about 20,4% of adults experienced chronic pain in 2019. Age-related increases in the prevalence of chronic pain were most pronounced in persons 65 years of age and older. Compared to Hispanic, non-Hispanic Asian, and non-Hispanic black individuals, non-Hispanic whites had the highest prevalence of chronic pain. About 23.6 percent of non-Hispanic white adults suffer from chronic discomfort. Therefore, given that both COX-2 selective and non-selective NSAIDs are frequently employed in the management of chronic pain, the increasing prevalence of chronic pain is anticipated to promote growth.

COVID-19 Impact Analysis

The infectious disease COVID-19 first surfaced in late December in the Chinese city of Wuhan's Hubei province. SARS-CoV-2, the virus that causes the acute respiratory syndrome is extremely contagious and spreads from person to person. The virus has spread to 213 nations since its outbreak in December 2019, prompting the World Health Organization to classify it as a pandemic. Governments and pharmaceutical and biotech businesses from all around the world are collaborating to combat the COVID-19 outbreak, from managing the medical supply chain to assisting in the creation of vaccinations. As a result, the demand for the COVID-19 vaccination and its treatment medications is predicted to propel the pharmaceutical and biotechnology sectors forward.

Market Growth Factors

Growing Incidence Of Chronic Pain

Pain that persists for more than 12 weeks without medication or treatment is referred to as chronic or persistent pain. Several people recover from pain due to injuries or operation and return to normalcy. However, there are situations when the pain lasts longer or appears suddenly without any prior history of an accident or surgery. One of the key factors propelling the market expansion for non-steroidal anti-inflammatory medications is the rising prevalence of disorders that cause pain and inflammation. These medications are being used more frequently to treat both acute & chronic pain. Ibuprofen & diclofenac are two medications that are frequently recommended to treat pain.

Increasing Preference Of People For Nsaids Over Opioids

The most often recommended medications for the management of mild to severe pain are NSAIDs and opioids. Opioid use, however, is linked to serious adverse outcomes. Since the dawn of civilization thousands of years ago, opioids have been used to relieve pain. Opioid analgesics are frequently used to treat dull, ill-localized pain, typically abdominal pain. Frequent doses may result in drug tolerance and dependency, and abruptly stopping an opioid painkiller may trigger a withdrawal crisis. Non-opioid, non-steroidal anti-inflammatory medicines (NSAIDs), which do not include opioids, are the most often prescribed analgesics for the management of pain. At larger doses, these medications also have antipyretic, analgesics, and anti-inflammatory properties.

Market Restraining Factors

Adverse Effects Of Nsaids Would Restrict Its Consumption

The market growth is anticipated to be constrained by adverse reactions to NSAID use, including allergic reactions, stomach pain, stomach ulcers, and dizziness. These pharmaceuticals are one of the most often prescribed medicines due to their widespread accessibility and anti-inflammatory effects. However, NSAID-related gastrointestinal issues are on the rise significantly globally, which could put a strain on the healthcare system. The most frequent reason for the most of emergency hospital admissions is GI bleeding related to NSAIDs. Additionally, its side effect is the most typical drug side in the United States.

Disease Indication Outlook

Based on disease indication, the Non-steroidal Anti-inflammatory Drugs Market is segmented into Arthritis, Migraine, Ophthalmic Diseases and Others. The arthritis segment acquired the highest revenue share in the Non-steroidal Anti-inflammatory Drugs Market in 2021. The overall incidence of arthritis & osteoarthritis, the growing senior population worldwide, the strong prescription rate for NSAIDs, and the rise in popularity of topical arthritis treatments are all contributing factors to the segment's growth.

Route of Administration Outlook

By Route of Administration, the Non-steroidal Anti-inflammatory Drugs Market is classified into Oral, Topical and Others. The oral segment garnered the maximum revenue share in the Non-steroidal Anti-inflammatory Drugs Market in 2021. It is due to the abundance of oral NSAIDs available for treating pain, headaches, fever, and migraines as well as the rise in OTC NSAID sales. To treat headaches and migraines, Johnson & Johnson Consumer Inc. provides their NSAID medication Motrin (ibuprofen), which is offered in dose forms such a tablet, liquid gel, capsule, and solution.

Distribution Channel Outlook

On the basis of distribution channel, the Non-steroidal Anti-inflammatory Drugs Market is divided into Hospital Pharmacy, Retail Pharmacy and Online Pharmacy. The hospital pharmacy segment acquired a significant revenue share in the Non-steroidal Anti-inflammatory Drugs Market in 2021. It is because non-steroidal anti-inflammatory medications are widely used to treat pain in hospitalized patients. Along with that, the rise in the number of hospitals across various nations of the world would escalate the growth of the segment over the forecast period.

Regional Outlook

Region-wise, the Non-steroidal Anti-inflammatory Drugs Market is analyzed across North America, Europe, Asia Pacific and LAMEA. North America emerged as the leading region in the Non-steroidal Anti-inflammatory Drugs Market with the maximum revenue share in 2021. Some of the key variables influencing the market's growth include the existence of a sizable number of manufacturers and the strategic actions made by industry participants. In addition, it is predicted that the prevalence of arthritis and chronic pain will rise during the forecast period, accelerating growth.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Dr. Reddy's Laboratories Ltd., Pfizer, Inc., GlaxoSmithKline PLC, Bayer AG, Teva Pharmaceuticals Industries Ltd., Eli Lilly And Company, Sanofi S.A., AstraZeneca PLC, Viatris, Inc., and Merck & Co., Inc.

Recent Strategies deployed in Non-steroidal Anti-inflammatory Drugs Market

Partnerships, Collaborations and Agreements:

May-2022: Dr. Reddy's Laboratories formed a partnership with South Korea-based HK inno.N Corporation. Through this partnership, Tegoprazan would offer a new option for the treatment of gastric acid-related as well as mobility-impaired diseases like Erosive/Non-erosive Gastroesophageal Reflux Disease (GERD / NERD), Nonsteroidal anti-inflammatory drug-mediated ulcers, Gastric and Duodenal ulcers, and Helicobacter pylori eradication.

Product Launches and Product Expansions:

Aug-2021: Dr Reddy's Laboratories introduced over-the-counter (OTC) Naproxen Sodium Tablets USP, 220 mg, the store-brand equivalent of Aleve, in the US market. This tablet is an over-the-counter non-steroidal anti-inflammatory drug (NSAID) for usage as a pain reliever and fever reducer.

May-2022: Dr. Reddy's Laboratories released Ketorolac Tromethamine Tablets USP, 10 mg, a therapeutic generic equivalent of the reference listed drug Toradol Tablets, 10 mg in the U.S. market. This product is a nonsteroidal anti-inflammatory drug (NSAID) demonstrated for the short-term management of moderately serious acute pain, which offers analgesia at the opioid stage and only as continuation treatment after intravenous or intramuscular dosing of ketorolac tromethamine, if necessary.

Approvals and Trails:

Feb-2022: Bayer received approval for Kerendia in the EU for adult people with chronic kidney disease related to type 2 diabetes. Kerendia is non-steroidal, which is a selective mineralocorticoid receptor (MR) antagonist to demonstrate positive kidney and cardiovascular (CV) results.

Jan-2022: Pfizer received approval from the United States (U.S.) Food and Drug Administration (FDA) for CIBINQO, an oral, once-daily, Janus kinase 1 (JAK1) inhibitor. CIBINQO is recommended for doses of 100 mg and 200 mg, along with the 200 mg dose being recommended for people for whom the medicine of 100 mg dose is less effective.

Dec-2020: GlaxoSmithKline got approval for BENLYSTA from the US Food and Drug Administration (FDA). This product is launched for the treatment of adult patients with active lupus nephritis (LN) who are getting standard therapy.

Sep-2020: Pfizer got the approval for XELJANZ from the United States (U.S.) Food and Drug Administration (FDA). This product is for the treatment of children and adolescents 2 years and elder with active polyarticular course juvenile idiopathic arthritis (pcJIA). In addition, the approval would make XELJANZ the first and only Janus kinase (JAK) inhibitor approved in the U.S. for the treatment of pcJIA.

Mar-2020: GlaxoSmithKline received approval from the U.S. Food and Drug Administration (FDA) for Advil Dual Action with Acetaminophen as an over-the-counter (OTC) product for pain relief. This product would offer relief for various symptoms and is the first formulation, which integrates ibuprofen and acetaminophen, two powerful ingredients related to OTC pain relief that would work in multiple ways.

Feb-2020: GlaxoSmithKline got approval from the U.S. Food and Drug Administration (FDA) for Voltaren Arthritis Pain (diclofenac sodium topical gel, 1% (NSAID)- arthritis pain reliever). This product is an over-the-counter (OTC) product for the temporary relief of arthritis pain in the hand, elbow, wrist, ankle foot, or knee in adults.

Scope of the Study

Market Segments covered in the Report:

By Route of Administration

Oral
Topical
Others

By Distribution Channel

Retail Pharmacy
Hospital Pharmacy
Online Pharmacy

By Disease Indication

Arthritis
Migraine
Ophthalmic Diseases
Others

By Geography

North America
- US
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA

Companies Profiled

Dr. Reddy's Laboratories Ltd.
Pfizer, Inc.
GlaxoSmithKline PLC
Bayer AG
Teva Pharmaceuticals Industries Ltd.
Eli Lilly And Company
Sanofi S.A.
AstraZeneca PLC
Viatris, Inc.
Merck & Co., Inc.

Unique Offerings from KBV Research

Exhaustive coverage
Highest number of market tables and figures
Subscription based model available
Guaranteed best price
Assured post sales research support with 10% customization free

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 Global Non-steroidal Anti-inflammatory Drugs Market, by Route of Administration
- 1.4.2 Global Non-steroidal Anti-inflammatory Drugs Market, by Distribution Channel
- 1.4.3 Global Non-steroidal Anti-inflammatory Drugs Market, by Disease Indication
- 1.4.4 Global Non-steroidal Anti-inflammatory Drugs Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview

2.1 Introduction
- 2.1.1 Overview
  - 2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints

Chapter 3. Recent Strategies deployed in Non-steroidal Anti-inflammatory Drugs Market

Chapter 4. Global Non-steroidal Anti-inflammatory Drugs Market by Route of Administration

4.1 Global Oral Market by Region
4.2 Global Topical Market by Region
4.3 Global Others Market by Region

Chapter 5. Global Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel

5.1 Global Retail Pharmacy Market by Region
5.2 Global Hospital Pharmacy Market by Region
5.3 Global Online Pharmacy Market by Region

Chapter 6. Global Non-steroidal Anti-inflammatory Drugs Market by Disease Indication

6.1 Global Arthritis Market by Region
6.2 Global Migraine Market by Region
6.3 Global Ophthalmic Diseases Market by Region
6.4 Global Others Market by Region

Chapter 7. Global Non-steroidal Anti-inflammatory Drugs Market by Region

7.1 North America Non-steroidal Anti-inflammatory Drugs Market
- 7.1.1 North America Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
  - 7.1.1.1 North America Oral Market by Country
  - 7.1.1.2 North America Topical Market by Country
  - 7.1.1.3 North America Others Market by Country
- 7.1.2 North America Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
  - 7.1.2.1 North America Retail Pharmacy Market by Country
  - 7.1.2.2 North America Hospital Pharmacy Market by Country
  - 7.1.2.3 North America Online Pharmacy Market by Country
- 7.1.3 North America Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
  - 7.1.3.1 North America Arthritis Market by Country
  - 7.1.3.2 North America Migraine Market by Country
  - 7.1.3.3 North America Ophthalmic Diseases Market by Country
  - 7.1.3.4 North America Others Market by Country
- 7.1.4 North America Non-steroidal Anti-inflammatory Drugs Market by Country
  - 7.1.4.1 US Non-steroidal Anti-inflammatory Drugs Market
    - 7.1.4.1.1 US Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
    - 7.1.4.1.2 US Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
    - 7.1.4.1.3 US Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
  - 7.1.4.2 Canada Non-steroidal Anti-inflammatory Drugs Market
    - 7.1.4.2.1 Canada Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
    - 7.1.4.2.2 Canada Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
    - 7.1.4.2.3 Canada Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
  - 7.1.4.3 Mexico Non-steroidal Anti-inflammatory Drugs Market
    - 7.1.4.3.1 Mexico Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
    - 7.1.4.3.2 Mexico Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
    - 7.1.4.3.3 Mexico Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
  - 7.1.4.4 Rest of North America Non-steroidal Anti-inflammatory Drugs Market
    - 7.1.4.4.1 Rest of North America Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
    - 7.1.4.4.2 Rest of North America Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
    - 7.1.4.4.3 Rest of North America Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
7.2 Europe Non-steroidal Anti-inflammatory Drugs Market
- 7.2.1 Europe Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
  - 7.2.1.1 Europe Oral Market by Country
  - 7.2.1.2 Europe Topical Market by Country
  - 7.2.1.3 Europe Others Market by Country
- 7.2.2 Europe Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
  - 7.2.2.1 Europe Retail Pharmacy Market by Country
  - 7.2.2.2 Europe Hospital Pharmacy Market by Country
  - 7.2.2.3 Europe Online Pharmacy Market by Country
- 7.2.3 Europe Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
  - 7.2.3.1 Europe Arthritis Market by Country
  - 7.2.3.2 Europe Migraine Market by Country
  - 7.2.3.3 Europe Ophthalmic Diseases Market by Country
  - 7.2.3.4 Europe Others Market by Country
- 7.2.4 Europe Non-steroidal Anti-inflammatory Drugs Market by Country
  - 7.2.4.1 Germany Non-steroidal Anti-inflammatory Drugs Market
    - 7.2.4.1.1 Germany Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
    - 7.2.4.1.2 Germany Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
    - 7.2.4.1.3 Germany Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
  - 7.2.4.2 UK Non-steroidal Anti-inflammatory Drugs Market
    - 7.2.4.2.1 UK Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
    - 7.2.4.2.2 UK Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
    - 7.2.4.2.3 UK Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
  - 7.2.4.3 France Non-steroidal Anti-inflammatory Drugs Market
    - 7.2.4.3.1 France Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
    - 7.2.4.3.2 France Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
    - 7.2.4.3.3 France Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
  - 7.2.4.4 Russia Non-steroidal Anti-inflammatory Drugs Market
    - 7.2.4.4.1 Russia Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
    - 7.2.4.4.2 Russia Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
    - 7.2.4.4.3 Russia Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
  - 7.2.4.5 Spain Non-steroidal Anti-inflammatory Drugs Market
    - 7.2.4.5.1 Spain Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
    - 7.2.4.5.2 Spain Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
    - 7.2.4.5.3 Spain Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
  - 7.2.4.6 Italy Non-steroidal Anti-inflammatory Drugs Market
    - 7.2.4.6.1 Italy Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
    - 7.2.4.6.2 Italy Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
    - 7.2.4.6.3 Italy Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
  - 7.2.4.7 Rest of Europe Non-steroidal Anti-inflammatory Drugs Market
    - 7.2.4.7.1 Rest of Europe Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
    - 7.2.4.7.2 Rest of Europe Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
    - 7.2.4.7.3 Rest of Europe Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
7.3 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market
- 7.3.1 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
  - 7.3.1.1 Asia Pacific Oral Market by Country
  - 7.3.1.2 Asia Pacific Topical Market by Country
  - 7.3.1.3 Asia Pacific Others Market by Country
- 7.3.2 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
  - 7.3.2.1 Asia Pacific Retail Pharmacy Market by Country
  - 7.3.2.2 Asia Pacific Hospital Pharmacy Market by Country
  - 7.3.2.3 Asia Pacific Online Pharmacy Market by Country
- 7.3.3 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
  - 7.3.3.1 Asia Pacific Arthritis Market by Country
  - 7.3.3.2 Asia Pacific Migraine Market by Country
  - 7.3.3.3 Asia Pacific Ophthalmic Diseases Market by Country
  - 7.3.3.4 Asia Pacific Others Market by Country
- 7.3.4 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Country
  - 7.3.4.1 China Non-steroidal Anti-inflammatory Drugs Market
    - 7.3.4.1.1 China Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
    - 7.3.4.1.2 China Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
    - 7.3.4.1.3 China Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
  - 7.3.4.2 Japan Non-steroidal Anti-inflammatory Drugs Market
    - 7.3.4.2.1 Japan Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
    - 7.3.4.2.2 Japan Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
    - 7.3.4.2.3 Japan Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
  - 7.3.4.3 India Non-steroidal Anti-inflammatory Drugs Market
    - 7.3.4.3.1 India Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
    - 7.3.4.3.2 India Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
    - 7.3.4.3.3 India Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
  - 7.3.4.4 South Korea Non-steroidal Anti-inflammatory Drugs Market
    - 7.3.4.4.1 South Korea Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
    - 7.3.4.4.2 South Korea Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
    - 7.3.4.4.3 South Korea Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
  - 7.3.4.5 Singapore Non-steroidal Anti-inflammatory Drugs Market
    - 7.3.4.5.1 Singapore Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
    - 7.3.4.5.2 Singapore Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
    - 7.3.4.5.3 Singapore Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
  - 7.3.4.6 Malaysia Non-steroidal Anti-inflammatory Drugs Market
    - 7.3.4.6.1 Malaysia Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
    - 7.3.4.6.2 Malaysia Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
    - 7.3.4.6.3 Malaysia Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
  - 7.3.4.7 Rest of Asia Pacific Non-steroidal Anti-inflammatory Drugs Market
    - 7.3.4.7.1 Rest of Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
    - 7.3.4.7.2 Rest of Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
    - 7.3.4.7.3 Rest of Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
7.4 LAMEA Non-steroidal Anti-inflammatory Drugs Market
- 7.4.1 LAMEA Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
  - 7.4.1.1 LAMEA Oral Market by Country
  - 7.4.1.2 LAMEA Topical Market by Country
  - 7.4.1.3 LAMEA Others Market by Country
- 7.4.2 LAMEA Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
  - 7.4.2.1 LAMEA Retail Pharmacy Market by Country
  - 7.4.2.2 LAMEA Hospital Pharmacy Market by Country
  - 7.4.2.3 LAMEA Online Pharmacy Market by Country
- 7.4.3 LAMEA Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
  - 7.4.3.1 LAMEA Arthritis Market by Country
  - 7.4.3.2 LAMEA Migraine Market by Country
  - 7.4.3.3 LAMEA Ophthalmic Diseases Market by Country
  - 7.4.3.4 LAMEA Others Market by Country
- 7.4.4 LAMEA Non-steroidal Anti-inflammatory Drugs Market by Country
  - 7.4.4.1 Brazil Non-steroidal Anti-inflammatory Drugs Market
    - 7.4.4.1.1 Brazil Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
    - 7.4.4.1.2 Brazil Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
    - 7.4.4.1.3 Brazil Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
  - 7.4.4.2 Argentina Non-steroidal Anti-inflammatory Drugs Market
    - 7.4.4.2.1 Argentina Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
    - 7.4.4.2.2 Argentina Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
    - 7.4.4.2.3 Argentina Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
  - 7.4.4.3 UAE Non-steroidal Anti-inflammatory Drugs Market
    - 7.4.4.3.1 UAE Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
    - 7.4.4.3.2 UAE Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
    - 7.4.4.3.3 UAE Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
  - 7.4.4.4 Saudi Arabia Non-steroidal Anti-inflammatory Drugs Market
    - 7.4.4.4.1 Saudi Arabia Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
    - 7.4.4.4.2 Saudi Arabia Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
    - 7.4.4.4.3 Saudi Arabia Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
  - 7.4.4.5 South Africa Non-steroidal Anti-inflammatory Drugs Market
    - 7.4.4.5.1 South Africa Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
    - 7.4.4.5.2 South Africa Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
    - 7.4.4.5.3 South Africa Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
  - 7.4.4.6 Nigeria Non-steroidal Anti-inflammatory Drugs Market
    - 7.4.4.6.1 Nigeria Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
    - 7.4.4.6.2 Nigeria Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
    - 7.4.4.6.3 Nigeria Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
  - 7.4.4.7 Rest of LAMEA Non-steroidal Anti-inflammatory Drugs Market
    - 7.4.4.7.1 Rest of LAMEA Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
    - 7.4.4.7.2 Rest of LAMEA Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
    - 7.4.4.7.3 Rest of LAMEA Non-steroidal Anti-inflammatory Drugs Market by Disease Indication

Chapter 8. Company Profiles

8.1 Dr. Reddy's Laboratories Ltd.
- 8.1.1 Company Overview
- 8.1.2 Financial Analysis
- 8.1.3 Segmental and Regional Analysis
- 8.1.4 Research & Development Expense
- 8.1.5 Recent strategies and developments:
  - 8.1.5.1 Partnerships, Collaborations, and Agreements:
  - 8.1.5.2 Product Launches and Product Expansions:
8.2 Pfizer, Inc.
- 8.2.1 Company Overview
- 8.2.2 Financial Analysis
- 8.2.3 Regional & Segmental Analysis
- 8.2.4 Research & Development Expense
- 8.2.5 Recent strategies and developments:
  - 8.2.5.1 Approvals and Trails:
8.3 GlaxoSmithKline PLC
- 8.3.1 Company Overview
- 8.3.2 Financial Analysis
- 8.3.3 Segmental and Regional Analysis
- 8.3.4 Research & Development Expense
- 8.3.5 Recent strategies and developments:
  - 8.3.5.1 Approvals and Trails:
8.4 Bayer AG
- 8.4.1 Company Overview
- 8.4.2 Financial Analysis
- 8.4.3 Segmental and Regional Analysis
- 8.4.4 Research & Development Expense
- 8.4.5 Recent strategies and developments:
  - 8.4.5.1 Approvals and Trails:
8.5 Teva Pharmaceutical Industries Ltd.
- 8.5.1 Company Overview
- 8.5.2 Financial Analysis
- 8.5.3 Regional Analysis
- 8.5.4 Research & Development Expenses
- 8.5.5 Recent strategies and developments:
  - 8.5.5.1 Product Launches and Product Expansions:
8.6 Eli Lilly And Company
- 8.6.1 Company Overview
- 8.6.2 Financial Analysis
- 8.6.3 Regional Analysis
- 8.6.4 Research & Development Expenses
- 8.6.5 Recent strategies and developments:
  - 8.6.5.1 Approvals and Trails:
8.7 Sanofi S.A.
- 8.7.1 Company Overview
- 8.7.2 Financial Analysis
- 8.7.3 Segmental and Regional Analysis
- 8.7.4 Research & Development Expense
8.8 AstraZeneca PLC
- 8.8.1 Company Overview
- 8.8.2 Financial Analysis
- 8.8.3 Regional Analysis
- 8.8.4 Research & Development Expenses
8.9 Viatris, Inc.
- 8.9.1 Company Overview
- 8.9.2 Financial Analysis
- 8.9.3 Segmental and Regional Analysis
- 8.9.4 Research & Development Expense
8.10. Merck & Co., Inc.
- 8.10.1 Company Overview
- 8.10.2 Financial Analysis
- 8.10.3 Segmental and Regional Analysis
- 8.10.4 Research & Development Expenses

LIST OF TABLES

TABLE 1 Global Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
TABLE 2 Global Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
TABLE 3 Global Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 4 Global Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 5 Global Oral Market by Region, 2018 - 2021, USD Million
TABLE 6 Global Oral Market by Region, 2022 - 2028, USD Million
TABLE 7 Global Topical Market by Region, 2018 - 2021, USD Million
TABLE 8 Global Topical Market by Region, 2022 - 2028, USD Million
TABLE 9 Global Others Market by Region, 2018 - 2021, USD Million
TABLE 10 Global Others Market by Region, 2022 - 2028, USD Million
TABLE 11 Global Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 12 Global Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 13 Global Retail Pharmacy Market by Region, 2018 - 2021, USD Million
TABLE 14 Global Retail Pharmacy Market by Region, 2022 - 2028, USD Million
TABLE 15 Global Hospital Pharmacy Market by Region, 2018 - 2021, USD Million
TABLE 16 Global Hospital Pharmacy Market by Region, 2022 - 2028, USD Million
TABLE 17 Global Online Pharmacy Market by Region, 2018 - 2021, USD Million
TABLE 18 Global Online Pharmacy Market by Region, 2022 - 2028, USD Million
TABLE 19 Global Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
TABLE 20 Global Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
TABLE 21 Global Arthritis Market by Region, 2018 - 2021, USD Million
TABLE 22 Global Arthritis Market by Region, 2022 - 2028, USD Million
TABLE 23 Global Migraine Market by Region, 2018 - 2021, USD Million
TABLE 24 Global Migraine Market by Region, 2022 - 2028, USD Million
TABLE 25 Global Ophthalmic Diseases Market by Region, 2018 - 2021, USD Million
TABLE 26 Global Ophthalmic Diseases Market by Region, 2022 - 2028, USD Million
TABLE 27 Global Others Market by Region, 2018 - 2021, USD Million
TABLE 28 Global Others Market by Region, 2022 - 2028, USD Million
TABLE 29 Global Non-steroidal Anti-inflammatory Drugs Market by Region, 2018 - 2021, USD Million
TABLE 30 Global Non-steroidal Anti-inflammatory Drugs Market by Region, 2022 - 2028, USD Million
TABLE 31 North America Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
TABLE 32 North America Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
TABLE 33 North America Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 34 North America Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 35 North America Oral Market by Country, 2018 - 2021, USD Million
TABLE 36 North America Oral Market by Country, 2022 - 2028, USD Million
TABLE 37 North America Topical Market by Country, 2018 - 2021, USD Million
TABLE 38 North America Topical Market by Country, 2022 - 2028, USD Million
TABLE 39 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 40 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 41 North America Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 42 North America Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 43 North America Retail Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 44 North America Retail Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 45 North America Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 46 North America Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 47 North America Online Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 48 North America Online Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 49 North America Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
TABLE 50 North America Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
TABLE 51 North America Arthritis Market by Country, 2018 - 2021, USD Million
TABLE 52 North America Arthritis Market by Country, 2022 - 2028, USD Million
TABLE 53 North America Migraine Market by Country, 2018 - 2021, USD Million
TABLE 54 North America Migraine Market by Country, 2022 - 2028, USD Million
TABLE 55 North America Ophthalmic Diseases Market by Country, 2018 - 2021, USD Million
TABLE 56 North America Ophthalmic Diseases Market by Country, 2022 - 2028, USD Million
TABLE 57 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 58 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 59 North America Non-steroidal Anti-inflammatory Drugs Market by Country, 2018 - 2021, USD Million
TABLE 60 North America Non-steroidal Anti-inflammatory Drugs Market by Country, 2022 - 2028, USD Million
TABLE 61 US Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
TABLE 62 US Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
TABLE 63 US Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 64 US Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 65 US Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 66 US Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 67 US Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
TABLE 68 US Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
TABLE 69 Canada Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
TABLE 70 Canada Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
TABLE 71 Canada Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 72 Canada Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 73 Canada Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 74 Canada Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 75 Canada Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
TABLE 76 Canada Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
TABLE 77 Mexico Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
TABLE 78 Mexico Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
TABLE 79 Mexico Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 80 Mexico Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 81 Mexico Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 82 Mexico Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 83 Mexico Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
TABLE 84 Mexico Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
TABLE 85 Rest of North America Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
TABLE 86 Rest of North America Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
TABLE 87 Rest of North America Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 88 Rest of North America Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 89 Rest of North America Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 90 Rest of North America Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 91 Rest of North America Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
TABLE 92 Rest of North America Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
TABLE 93 Europe Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
TABLE 94 Europe Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
TABLE 95 Europe Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 96 Europe Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 97 Europe Oral Market by Country, 2018 - 2021, USD Million
TABLE 98 Europe Oral Market by Country, 2022 - 2028, USD Million
TABLE 99 Europe Topical Market by Country, 2018 - 2021, USD Million
TABLE 100 Europe Topical Market by Country, 2022 - 2028, USD Million
TABLE 101 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 102 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 103 Europe Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 104 Europe Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 105 Europe Retail Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 106 Europe Retail Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 107 Europe Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 108 Europe Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 109 Europe Online Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 110 Europe Online Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 111 Europe Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
TABLE 112 Europe Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
TABLE 113 Europe Arthritis Market by Country, 2018 - 2021, USD Million
TABLE 114 Europe Arthritis Market by Country, 2022 - 2028, USD Million
TABLE 115 Europe Migraine Market by Country, 2018 - 2021, USD Million
TABLE 116 Europe Migraine Market by Country, 2022 - 2028, USD Million
TABLE 117 Europe Ophthalmic Diseases Market by Country, 2018 - 2021, USD Million
TABLE 118 Europe Ophthalmic Diseases Market by Country, 2022 - 2028, USD Million
TABLE 119 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 120 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 121 Europe Non-steroidal Anti-inflammatory Drugs Market by Country, 2018 - 2021, USD Million
TABLE 122 Europe Non-steroidal Anti-inflammatory Drugs Market by Country, 2022 - 2028, USD Million
TABLE 123 Germany Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
TABLE 124 Germany Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
TABLE 125 Germany Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 126 Germany Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 127 Germany Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 128 Germany Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 129 Germany Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
TABLE 130 Germany Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
TABLE 131 UK Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
TABLE 132 UK Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
TABLE 133 UK Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 134 UK Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 135 UK Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 136 UK Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 137 UK Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
TABLE 138 UK Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
TABLE 139 France Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
TABLE 140 France Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
TABLE 141 France Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 142 France Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 143 France Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 144 France Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 145 France Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
TABLE 146 France Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
TABLE 147 Russia Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
TABLE 148 Russia Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
TABLE 149 Russia Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 150 Russia Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 151 Russia Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 152 Russia Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 153 Russia Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
TABLE 154 Russia Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
TABLE 155 Spain Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
TABLE 156 Spain Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
TABLE 157 Spain Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 158 Spain Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 159 Spain Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 160 Spain Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 161 Spain Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
TABLE 162 Spain Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
TABLE 163 Italy Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
TABLE 164 Italy Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
TABLE 165 Italy Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 166 Italy Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 167 Italy Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 168 Italy Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 169 Italy Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
TABLE 170 Italy Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
TABLE 171 Rest of Europe Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
TABLE 172 Rest of Europe Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
TABLE 173 Rest of Europe Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 174 Rest of Europe Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 175 Rest of Europe Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 176 Rest of Europe Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 177 Rest of Europe Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
TABLE 178 Rest of Europe Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
TABLE 179 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
TABLE 180 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
TABLE 181 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 182 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 183 Asia Pacific Oral Market by Country, 2018 - 2021, USD Million
TABLE 184 Asia Pacific Oral Market by Country, 2022 - 2028, USD Million
TABLE 185 Asia Pacific Topical Market by Country, 2018 - 2021, USD Million
TABLE 186 Asia Pacific Topical Market by Country, 2022 - 2028, USD Million
TABLE 187 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 188 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 189 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 190 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 191 Asia Pacific Retail Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 192 Asia Pacific Retail Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 193 Asia Pacific Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 194 Asia Pacific Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 195 Asia Pacific Online Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 196 Asia Pacific Online Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 197 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
TABLE 198 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
TABLE 199 Asia Pacific Arthritis Market by Country, 2018 - 2021, USD Million
TABLE 200 Asia Pacific Arthritis Market by Country, 2022 - 2028, USD Million
TABLE 201 Asia Pacific Migraine Market by Country, 2018 - 2021, USD Million
TABLE 202 Asia Pacific Migraine Market by Country, 2022 - 2028, USD Million
TABLE 203 Asia Pacific Ophthalmic Diseases Market by Country, 2018 - 2021, USD Million
TABLE 204 Asia Pacific Ophthalmic Diseases Market by Country, 2022 - 2028, USD Million
TABLE 205 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 206 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 207 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Country, 2018 - 2021, USD Million
TABLE 208 Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Country, 2022 - 2028, USD Million
TABLE 209 China Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
TABLE 210 China Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
TABLE 211 China Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 212 China Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 213 China Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 214 China Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 215 China Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
TABLE 216 China Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
TABLE 217 Japan Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
TABLE 218 Japan Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
TABLE 219 Japan Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 220 Japan Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 221 Japan Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 222 Japan Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 223 Japan Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
TABLE 224 Japan Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
TABLE 225 India Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
TABLE 226 India Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
TABLE 227 India Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 228 India Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 229 India Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 230 India Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 231 India Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
TABLE 232 India Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
TABLE 233 South Korea Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
TABLE 234 South Korea Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
TABLE 235 South Korea Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 236 South Korea Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 237 South Korea Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 238 South Korea Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 239 South Korea Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
TABLE 240 South Korea Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
TABLE 241 Singapore Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
TABLE 242 Singapore Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
TABLE 243 Singapore Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 244 Singapore Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 245 Singapore Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 246 Singapore Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 247 Singapore Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
TABLE 248 Singapore Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
TABLE 249 Malaysia Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
TABLE 250 Malaysia Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
TABLE 251 Malaysia Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 252 Malaysia Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 253 Malaysia Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 254 Malaysia Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 255 Malaysia Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
TABLE 256 Malaysia Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
TABLE 257 Rest of Asia Pacific Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
TABLE 258 Rest of Asia Pacific Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
TABLE 259 Rest of Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 260 Rest of Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 261 Rest of Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 262 Rest of Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 263 Rest of Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
TABLE 264 Rest of Asia Pacific Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
TABLE 265 LAMEA Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
TABLE 266 LAMEA Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
TABLE 267 LAMEA Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 268 LAMEA Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 269 LAMEA Oral Market by Country, 2018 - 2021, USD Million
TABLE 270 LAMEA Oral Market by Country, 2022 - 2028, USD Million
TABLE 271 LAMEA Topical Market by Country, 2018 - 2021, USD Million
TABLE 272 LAMEA Topical Market by Country, 2022 - 2028, USD Million
TABLE 273 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 274 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 275 LAMEA Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 276 LAMEA Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 277 LAMEA Retail Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 278 LAMEA Retail Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 279 LAMEA Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 280 LAMEA Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 281 LAMEA Online Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 282 LAMEA Online Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 283 LAMEA Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
TABLE 284 LAMEA Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
TABLE 285 LAMEA Arthritis Market by Country, 2018 - 2021, USD Million
TABLE 286 LAMEA Arthritis Market by Country, 2022 - 2028, USD Million
TABLE 287 LAMEA Migraine Market by Country, 2018 - 2021, USD Million
TABLE 288 LAMEA Migraine Market by Country, 2022 - 2028, USD Million
TABLE 289 LAMEA Ophthalmic Diseases Market by Country, 2018 - 2021, USD Million
TABLE 290 LAMEA Ophthalmic Diseases Market by Country, 2022 - 2028, USD Million
TABLE 291 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 292 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 293 LAMEA Non-steroidal Anti-inflammatory Drugs Market by Country, 2018 - 2021, USD Million
TABLE 294 LAMEA Non-steroidal Anti-inflammatory Drugs Market by Country, 2022 - 2028, USD Million
TABLE 295 Brazil Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
TABLE 296 Brazil Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
TABLE 297 Brazil Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 298 Brazil Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 299 Brazil Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 300 Brazil Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 301 Brazil Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
TABLE 302 Brazil Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
TABLE 303 Argentina Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
TABLE 304 Argentina Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
TABLE 305 Argentina Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 306 Argentina Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 307 Argentina Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 308 Argentina Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 309 Argentina Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
TABLE 310 Argentina Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
TABLE 311 UAE Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
TABLE 312 UAE Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
TABLE 313 UAE Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 314 UAE Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 315 UAE Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 316 UAE Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 317 UAE Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
TABLE 318 UAE Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
TABLE 319 Saudi Arabia Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
TABLE 320 Saudi Arabia Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
TABLE 321 Saudi Arabia Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 322 Saudi Arabia Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 323 Saudi Arabia Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 324 Saudi Arabia Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 325 Saudi Arabia Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
TABLE 326 Saudi Arabia Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
TABLE 327 South Africa Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
TABLE 328 South Africa Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
TABLE 329 South Africa Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 330 South Africa Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 331 South Africa Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 332 South Africa Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 333 South Africa Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
TABLE 334 South Africa Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million

TABLE 335 Nigeria Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
TABLE 336 Nigeria Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
TABLE 337 Nigeria Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 338 Nigeria Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 339 Nigeria Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 340 Nigeria Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 341 Nigeria Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
TABLE 342 Nigeria Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
TABLE 343 Rest of LAMEA Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
TABLE 344 Rest of LAMEA Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
TABLE 345 Rest of LAMEA Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 346 Rest of LAMEA Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 347 Rest of LAMEA Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 348 Rest of LAMEA Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 349 Rest of LAMEA Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
TABLE 350 Rest of LAMEA Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
TABLE 351 key information - Dr. Reddy's Laboratories Ltd.
TABLE 352 Key Information - Pfizer, Inc.
TABLE 353 Key Information - GlaxoSmithKline PLC
TABLE 354 Key Information - Bayer AG
TABLE 355 Key Information - Teva Pharmaceuticals Industries Ltd.
TABLE 356 Key Information - Eli Lilly And Company
TABLE 357 Key Information - Sanofi S.A.
TABLE 358 KEY INFORMATION - ASTRAZENECA PLC
TABLE 359 key information - Viatris, Inc.
TABLE 360 KEY INFORMATION - MERCK & CO., INC.

List of Figures

FIG 1 Methodology for the research
FIG 2 Global Non-steroidal Anti-inflammatory Drugs Market Share by Route of Administration, 2021
FIG 3 Global Non-steroidal Anti-inflammatory Drugs Market Share by Route of Administration, 2028
FIG 4 Global Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2028, USD Million
FIG 5 Global Non-steroidal Anti-inflammatory Drugs Market Share by Distribution Channel, 2021
FIG 6 Global Non-steroidal Anti-inflammatory Drugs Market Share by Distribution Channel, 2028
FIG 7 Global Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2028, USD Million
FIG 8 Global Non-steroidal Anti-inflammatory Drugs Market Share by Disease Indication, 2021
FIG 9 Global Non-steroidal Anti-inflammatory Drugs Market Share by Disease Indication, 2028
FIG 10 Global Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2028, USD Million
FIG 11 Global Non-steroidal Anti-inflammatory Drugs Market Share by Region, 2021
FIG 12 Global Non-steroidal Anti-inflammatory Drugs Market Share by Region, 2028
FIG 13 Global Non-steroidal Anti-inflammatory Drugs Market by Region, 2018 - 2028, USD Million
FIG 14 Recent strategies and developments: Dr. Reddy's Laboratories Ltd.

Global Non-steroidal Anti-inflammatory Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration, By Distribution Channel, By Route of Disease Indication, By Regional Outlook and Forecast, 2022 - 2028

Description

Table of Contents